Description
- Molecule: Fragment 176-191
- Laboratory: Ultima Pharma
- Form: Subcutaneous Injection
- Concentration: 10 mg/vial
- Presentation: Box of 1 bottle
- Recommended dosage: 300 mcg 2 times daily (before breakfast and before bedtime)
- Dose injection: 300 mcg = 0.33ml (33 units in insulin syringe)
Fragment 176-191 from Ultima Pharma is a fragment of an HGH peptide. It has been developed to isolate specific characteristics of fat loss with growth hormone. Its profile is ideal for athletes not seeking growth but maximum efficiency with losing body fat suitable for a dry program.
Reviews
There are no reviews yet.